# US Home Infusion Therapy Devices Market > US Home Infusion Therapy Devices Market Research Report By Device Type (Infusion Pumps, Syringe Pumps, Ambulatory Pumps, Enteral Feeding Pumps), By Therapy Type (Antibiotic Therapy, Chemotherapy, Nutrition Therapy, Pain Management), By End User (Hospitals, Home Care Settings, Nursing Homes) and By Components (Infusion Set, Catheters, Accessories, Software Solutions) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 5.09% - **2024:** $ 1,434.3 Million - **2025:** $ 1,507.31 Million - **2035:** $ 2,477 Million - **Key Players:** Baxter International Inc (US), B. Braun Melsungen AG (DE), Fresenius Kabi AG (DE), Medtronic plc (IE), Smiths Medical (US), Terumo Corporation (JP), ICU Medical Inc (US), Halyard Health Inc (US) **Report ID:** MRFR/Pharma/18122-HCR · **Pages:** 100 · **Author:** Rahul Gotadki & Garvit Vyas · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/us-home-infusion-therapy-devices-market-19669 --- ## Market Summary ## **US Home Infusion Therapy Devices Market Overview** As per MRFR analysis, the US Home Infusion Therapy Devices Market Size was estimated at 4.62 (USD Billion) in 2023. The US Home Infusion Therapy Devices Market Industry is expected to grow from 5(USD Billion) in 2024 to 10.5 (USD Billion) by 2035. The US Home Infusion Therapy Devices Market CAGR (growth rate) is expected to be around 6.978% during the forecast period (2025 - 2035). ### **Key Market Trends Highlighted** The US Home Infusion Therapy Devices Market is witnessing significant growth, driven by an increasing preference for home healthcare solutions. Factors such as the rising aging population, chronic diseases, and a shift towards outpatient care are fueling this trend. Additionally, advancements in technology are enhancing the safety and efficacy of infusion therapy, making it more appealing for both healthcare providers and patients. Healthcare reforms that emphasize cost-effective treatments further drive the adoption of home infusion therapies, as they reduce hospital stays and associated costs. Opportunities within this market are abound, particularly in developing advanced infusion devices and integrated delivery systems. The emphasis on personalized medicine is opening avenues for companies to create tailored infusion solutions, catering to specific patient needs. Moreover, home healthcare providers can expand their offerings through partnerships with technology firms to incorporate telehealth solutions, thus increasing patient engagement and monitoring efficiency. In recent times, the US market has also seen a rise in demand for infusion devices that are user-friendly, portable, and equipped with smart technology for remote monitoring. The ongoing developments related to telemedicine and home healthcare services have reshaped how patients receive treatment, further stimulating interest in home infusion therapy. Regulatory policies supporting patient care at home and the push to reduce hospital readmissions are reinforcing this trend. As more patients opt for home-based therapies due to comfort and convenience, the market will likely continue expanding to meet these evolving needs. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **US Home Infusion Therapy Devices Market Drivers** ### **Increasing Prevalence of Chronic Diseases** The US [Home Infusion Therapy Devices Market](../../../reports/home-infusion-therapy-devices-market-7906) Industry is significantly driven by the increasing prevalence of chronic diseases, such as diabetes, heart disease, and cancer. According to the Centers for Disease Control and Prevention (CDC), approximately 6.2 million adults in the US are diagnosed with diabetes, which requires ongoing treatment that can be effectively administered through home infusion therapy devices. The rising demand for effective treatment options is further emphasized by the American Cancer Society, which reports that cancer rates are expected to rise by 24% by 2035, highlighting the urgent need for home-based healthcare solutions. As a result, healthcare providers and pharmaceutical companies are investing in Research and Development to enhance home infusion products, making them safer and more user-friendly, thereby expanding market growth in the US Home Infusion Therapy Devices Market. ### **Technological Advancements in Infusion Systems** Technological advancements in infusion systems play a pivotal role in the growth of the US Home Infusion Therapy Devices Market Industry. The integration of smart technology, including mobile health applications and remote monitoring, is transforming how infusion therapy is administered at home. According to the US Food and Drug Administration (FDA), there has been a steady increase in the number of infusion devices receiving regulatory approval, which serves as a testament to the rapid innovation in this field. Leading companies such as Baxter International and Smiths Medical are at the forefront of developing advanced infusion delivery systems that enhance patient safety and ease of use, ultimately driving market expansion. ### **Rising Focus on Cost-Effective Healthcare Solutions** The trend towards cost-effective healthcare solutions is a significant driver for the US Home Infusion Therapy Devices Market Industry. The increasing pressure on healthcare systems to reduce expenditures has led to a growing preference for home-based treatment options. The Medicare Payment Advisory Commission reported that home infusion therapy can reduce hospital readmission rates and associated costs by approximately 30%, providing a compelling argument for healthcare providers and payers. As a result, various stakeholders in the healthcare sector are increasingly promoting home infusion therapy as a viable alternative to traditional inpatient treatments, sparking growth in this market segment. ### **Expansion of Home Healthcare Services** The expansion of home healthcare services is a crucial factor fueling the US Home Infusion Therapy Devices Market Industry. As the demand for at-home care increases, fueled by an aging population and a preference for home-based care, healthcare providers are broadening their services to include home infusion therapy. According to the National Association for Home Care and Hospice, an estimated 12 million patients receive home healthcare each year in the US, with this number expected to rise due to demographic changes. This shift in care delivery models encourages the adoption of home infusion devices, creating significant opportunities for market participants to enhance their offerings and meet the growing needs of patients. ## **US Home Infusion Therapy Devices Market Segment Insights** ### **Home Infusion Therapy Devices Market Device Type Insights** The Device Type segment within the US Home Infusion Therapy Devices Market plays a pivotal role in shaping the overall landscape of the industry, which is experiencing substantial growth driven by technological advancements and increasing patient demand for at-home care solutions. Infusion Pumps are essential devices used for delivering medications and nutrients efficiently, providing precision and control that are crucial for patient treatment outcomes. Syringe Pumps offer versatility, often preferred for administering smaller volumes of fluids, and are widely utilized in cases where accuracy is paramount. Ambulatory Pumps facilitate patient mobility by allowing individuals to receive therapy on the go, thereby enhancing comfort and independence while managing chronic conditions. Enteral Feeding Pumps are specialized devices aimed at patients requiring nutritional support, ensuring that timely and adequate food intake is maintained even outside of traditional clinical settings. The integration of these devices is essential for addressing the growing patient population seeking home healthcare services, driven by the rising prevalence of chronic diseases and a significant shift towards personalized medicine. Furthermore, home-based infusion therapy not only curtails hospital stays, thereby reducing healthcare costs, but also empowers patients to partake in their treatment journey from the comfort of their homes. Market dynamics reveal a notable trend toward the incorporation of smart technology in these devices, allowing for enhanced monitoring and user-friendly interfaces that improve patient safety and adherence to therapy protocols. Given these factors, the Device Type segment is projected to continue to evolve, paving the way for innovative solutions that cater to diverse treatment needs and setting a foundation for robust future growth within the US Home Infusion Therapy Devices Market. As patient preferences shift towards home treatment options, the significance of these devices in healthcare delivery is anticipated to expand, supported by a favorable regulatory framework and an increasing focus on value-based care initiatives. The collective momentum of these factors positions the Device Type segment as a key driver in transforming home infusion therapy into a more practical and effective option for a wide range of patients. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **Home Infusion Therapy Devices Market Therapy Type Insights** The US Home Infusion Therapy Devices Market has shown significant growth attributed to the increasing demand across various Therapy Types such as Antibiotic Therapy, Chemotherapy, Nutrition Therapy, and Pain Management. Antibiotic Therapy is particularly critical for managing infections and is gaining traction due to the rising prevalence of chronic infections and the aging population in the US. Chemotherapy remains essential for cancer management, with patients preferring home-based therapies for convenience and comfort. Nutrition Therapy, especially for patients with malnutrition or specific dietary needs, is experiencing increased adoption, thereby improving patient quality of life. Additionally, Pain Management therapy is vital for patients suffering from chronic pain conditions, offering a significant alternative to traditional pain relief methods. This diversity in therapy types underscores the US Home Infusion Therapy Devices Market segmentation, revealing distinct needs and growth potentials. The growing trend towards home-based healthcare solutions, catalyzed by advancements in technology, challenges for healthcare access, and evolving patient preferences, supports the expansion of all these therapy types in the market. Each segment presents unique opportunities, particularly in enhancing patient compliance and management through tailored home infusion solutions. ### **Home Infusion Therapy Devices Market End User Insights** The End User segment of the US Home Infusion Therapy Devices Market plays a vital role in shaping the overall dynamics of this industry. Hospitals serve as a critical hub for the administration of these devices, supporting complex cases that require specialized care. With an increasing focus on patient-centered care, Home Care Settings are gaining significant traction, allowing patients to receive treatment in the comfort of their homes, thereby improving recovery experiences and overall satisfaction. Nursing Homes, on the other hand, are essential for managing chronic conditions among elderly populations, forming a crucial part of the healthcare continuum in the US. This growing trend can be attributed to the US government's emphasis on reducing hospital stays, resulting in an increased demand for effective home-based therapies. The segmentation of the US Home Infusion Therapy Devices Market illustrates the diverse needs of various patient populations, highlighting the opportunities for tailored solutions that enhance patient outcomes and operational efficiency across these different settings. Moreover, the aging population and rising prevalence of chronic diseases are expected to drive growth within these specific user segments, making them increasingly important in addressing contemporary healthcare challenges. ### **Home Infusion Therapy Devices Market Components Insights** The Components segment of the US Home Infusion Therapy Devices Market plays a crucial role in enhancing the efficiency and safety of home-based treatment protocols. This segment includes essential elements such as Infusion Sets, Catheters, Accessories, and Software Solutions, each being vital for patient care and treatment management. Infusion Sets are instrumental in delivering medications directly into the bloodstream, ensuring precise dosing and minimizing complications. Catheters facilitate easy access to veins while reducing the risk of infections, thus making them indispensable for patients requiring long-term therapy. Meanwhile, Accessories are essential for maintaining the integrity and functionality of infusion systems. Software Solutions are increasingly important as they support healthcare professionals in monitoring treatment progress and managing patient data more efficiently. This market is witnessing steady growth, driven by factors such as the increasing prevalence of chronic diseases in the US and the growing preference for home healthcare services. With technological advancements and a rising aging population, the Components segment is poised to become increasingly significant in the overall landscape of home infusion therapy. ## **US Home Infusion Therapy Devices Market Key Players and Competitive Insights** The US Home Infusion Therapy Devices Market has been experiencing considerable growth, driven by an increasing number of patients opting for home-based treatment solutions. This shift is attributed to various factors, including the rising preference for home healthcare services, technological advancements in infusion delivery systems, and the cost-effective nature of home therapies as compared to hospital stays. The landscape is marked by a mix of established players who have significant market share and new entrants looking to capitalize on the growing demand for personalized care solutions. As competition intensifies, companies are focusing on innovation, product differentiation, and strategic partnerships to enhance their market position, ensuring they meet evolving patient needs and regulatory requirements. ### **Parker Hannifin** Parker Hannifin has emerged as a strong player within the US Home Infusion Therapy Devices Market, recognized for its commitment to quality and innovation. The company's strengths lie in its advanced fluid control systems, which provide reliable and accurate infusion therapies for patients in home settings. Parker Hannifin has built a reputation for delivering cutting-edge technology and solutions designed to enhance patient outcomes and streamline healthcare provider workflows. Additionally, its robust distribution network and strong customer support contribute to its market presence, allowing for effective reach within the highly competitive home infusion segment. The company continues to invest in research and development, ensuring that its product offerings remain at the forefront of therapy advancements, thus reinforcing its competitive advantage in the market. ### **C.R. Bard** C.R. Bard plays a significant role in the US Home Infusion Therapy Devices Market, focusing on providing a wide range of products designed specifically for infusion therapy. With a robust portfolio that includes catheters, infusion sets, and related accessories, C.R. Bard is well-positioned to meet the demands of healthcare professionals and patients alike. The company has established a strong market presence, characterized by its focus on quality, safety, and innovation. C.R. Bard is recognized for its strategic mergers and acquisitions, which have bolstered its capabilities and expanded its product offerings within the home infusion space. Its commitment to research and development fosters ongoing product innovation, pushing the boundaries of infusion technology. These strengths enable C.R. Bard to maintain a competitive edge and ensure it remains a trusted supplier within the home healthcare sector in the United States. ### **Key Companies** Key Companies in the US Home Infusion Therapy Devices Market Include: ## **US Home Infusion Therapy Devices Market Industry Developments** The US Home Infusion Therapy Devices Market has recently been influenced by significant developments, including advancements in technology and an increasing shift towards home healthcare. Companies such as Baxter International and Medtronic are focusing on innovative infusion devices designed to enhance patient safety and comfort. In October 2023, C.R. Bard announced a strategic partnership aimed at expanding their product range in the home infusion sector. Growth in market valuation for firms like Fresenius Kabi and B. Braun Melsungen is also notable, with recent projections indicating a surge in demand for at-home healthcare solutions driven by the aging population and preference for at-home treatments. The COVID-19 pandemic catalyzed changes in healthcare delivery, intensifying interest in home infusion therapies. In terms of mergers and acquisitions, Smiths Medical completed the acquisition of CareFusion in September 2022 to strengthen its portfolio in the home infusion segment. Furthermore, in July 2022, ICU Medical acquired the assets of Halyard Health, further consolidating its position in the market. Overall, the landscape of the US Home Infusion Therapy Devices Market continues to evolve, supported by a focus on innovation and partnerships. ## **US Home Infusion Therapy Devices Market Segmentation Insights** ### **Home Infusion Therapy Devices Market Device Type Outlook** ### **Home Infusion Therapy Devices Market Therapy Type Outlook** ### **Home Infusion Therapy Devices Market End User Outlook** ### **Home Infusion Therapy Devices Market Components Outlook** ## Market Drivers ### Rising Prevalence of Chronic Diseases The increasing incidence of chronic diseases in the US is a primary driver for the home infusion-therapy-devices market. Conditions such as diabetes, cancer, and heart disease necessitate ongoing treatment, often requiring infusion therapies. According to the Centers for Disease Control and Prevention (CDC), approximately 60% of adults in the US have at least one chronic condition, which underscores the demand for effective home-based treatment options. This trend is likely to propel the market forward as patients seek convenient and effective ways to manage their health at home, reducing the need for frequent hospital visits. The home infusion-therapy-devices market is thus positioned to grow as healthcare systems adapt to meet the needs of this expanding patient population. ### Shift Towards Home Healthcare Services The ongoing shift towards home healthcare services is a significant driver for the home infusion therapy devices market. Patients increasingly prefer receiving care in the comfort of their homes, which is often seen as a more convenient and less stressful option compared to traditional hospital settings. This trend is supported by a growing body of evidence suggesting that home-based care can lead to better patient outcomes and lower healthcare costs. The home infusion-therapy-devices market is likely to benefit from this shift, as healthcare providers expand their services to include home infusion therapies, thereby enhancing patient access to necessary treatments while reducing the burden on healthcare facilities. ### Cost-Effectiveness of Home Infusion Therapy The cost-effectiveness of home infusion therapy is emerging as a significant driver for the home infusion-therapy-devices market. Home-based treatments can often reduce overall healthcare costs by minimizing hospital stays and associated expenses. According to various studies, home infusion therapy can save healthcare systems up to 50% compared to traditional inpatient care. This financial incentive is likely to encourage healthcare providers and insurers to promote home infusion therapies as a viable alternative. As the focus on cost containment in healthcare continues to grow, the home infusion-therapy-devices market is expected to expand, driven by the economic advantages of home-based care. ### Technological Innovations in Infusion Devices Technological advancements in infusion devices are significantly influencing the home infusion-therapy-devices market. Innovations such as smart infusion pumps, which offer enhanced accuracy and safety features, are becoming increasingly prevalent. These devices often include features like dose error reduction systems and wireless connectivity, allowing for better patient monitoring and data collection. The market for infusion pumps alone is projected to reach approximately $5 billion by 2026, indicating a robust growth trajectory. As healthcare providers and patients alike recognize the benefits of these advanced technologies, the demand for home infusion-therapy-devices is expected to rise, facilitating more effective and safer home care solutions. ### Aging Population and Increased Demand for Home Care The aging population in the US is a critical factor driving the home infusion therapy devices market. As the baby boomer generation continues to age, the demand for home healthcare services, including infusion therapies, is expected to rise. The US Census Bureau projects that by 2030, all baby boomers will be over 65 years old, leading to a substantial increase in the number of individuals requiring chronic disease management and long-term care. This demographic shift is likely to create a robust market for home infusion-therapy-devices, as older adults often prefer receiving care at home, where they feel more comfortable and secure. ## Future Outlook The [Home Infusion Therapy Devices Market](https://www.marketresearchfuture.com/reports/home-infusion-therapy-devices-market-7906) is projected to grow at a 5.09% CAGR from 2025 to 2035, driven by technological advancements, increasing patient preference for home care, and cost-effective solutions. **New opportunities:** - Development of integrated telehealth platforms for remote patient monitoring. - Expansion of customizable infusion systems tailored for specific therapies. - Partnerships with home healthcare providers to enhance service delivery and accessibility. By 2035, the market is expected to achieve substantial growth, reflecting evolving healthcare dynamics. ## Segment Insights ### By Device Type: Infusion Pumps (Largest) vs. IV Sets (Fastest-Growing) In the US home infusion-therapy-devices market, Infusion Pumps hold the largest market share, benefiting from widespread adoption due to their advanced features and ease of use. IV Sets, while not the largest, are exhibiting the fastest growth rate as they become increasingly essential for effective medication delivery, reflecting shifting preferences among healthcare providers. Growth trends indicate a robust demand for Infusion Pumps, driven by technological advancements and a growing patient population requiring home infusion therapies. Conversely, the rapid growth of IV Sets can be attributed to their adaptability and integration with digital health technologies, enabling better tracking and management of infused therapies, making them a critical component of home care systems. Infusion Pumps (Dominant) vs. Syringe Pumps (Emerging) Infusion Pumps are recognized as the dominant force in the market due to their capacity for delivering precise dosages of medications over extended periods, which is vital for chronic disease management. These devices are highly valued for their reliability and advanced features such as programmable settings and patient safety alarms, ensuring effective treatment. In contrast, Syringe Pumps are emerging as a noteworthy alternative, particularly valued for their compact size and versatility in administering smaller volumes of medication. Their growth is supported by a shift towards more personalized treatment regimens and the increasing prevalence of outpatient care, positioning them as attractive options for healthcare providers. ### By Application: Antibiotics (Largest) vs. Pain Management (Fastest-Growing) In the US home infusion-therapy-devices market, Antibiotics hold the largest market share among the application segments, driven by a growing incidence of bacterial infections and the need for effective at-home treatment options. Pain Management is gaining traction as an emerging segment, supported by an increased focus on palliative care and the need to address chronic pain effectively through home-based therapies. The growth trends in this sector are significantly influenced by an aging population and rising healthcare costs, which encourage patients to seek home care solutions for chronic illnesses. The increased acceptance of home-infused therapies over traditional hospital settings is paving the way for innovative product developments and expanding the market reach, particularly in Pain Management, which is expected to see robust growth in the coming years. Antibiotics (Dominant) vs. Pain Management (Emerging) Antibiotics represent the dominant application in the US home infusion-therapy-devices market, characterized by a broad usage in treating various infections. This segment benefits from advanced delivery systems that facilitate effective and convenient patient administration at home. Pain Management, on the other hand, is emerging as a vital sector, focusing on innovative solutions for those suffering from chronic pain and terminal conditions. The growth of this segment is fueled by an increasing emphasis on patient comfort and reducing hospitalization times, with a growing array of products designed for easy use at home. Both segments are crucial in optimizing patient care, reflecting the changing landscape of healthcare delivery toward more personalized, home-based solutions. ### By End User: Homecare Settings (Largest) vs. Hospitals (Fastest-Growing) In the US home infusion-therapy-devices market, the distribution of market share among various end users reveals that homecare settings hold the largest share, driven by the increasing preference for at-home treatment and patient-centered care. Hospitals closely follow, representing a significant segment due to their ongoing need for advanced infusion devices that support complex therapies, particularly in critical care. Ambulatory surgical centers and nursing homes, while important, remain smaller players within this competitive landscape. Growth trends indicate that homecare settings are not only dominating the market but are expected to see consistent growth as more patients transition to home-based therapies. This shift is fueled by advancements in technology, increased awareness of home health options, and favorable reimbursement policies. Meanwhile, hospitals are experiencing rapid growth as they adopt more sophisticated infusion technologies to enhance patient outcomes, making them the fastest-growing segment. Homecare Settings (Dominant) vs. Hospitals (Emerging) Homecare settings are the dominant players in the US home infusion-therapy-devices market, offering a variety of devices tailored for at-home administration of therapies. These settings are characterized by their focus on patient convenience and comfort, which in turn drives adoption and usage rates. On the other hand, hospitals represent the emerging segment, where there is a robust demand for innovative solutions to efficiently manage critical infusion therapies. Hospitals are investing in advanced infusion technologies to improve care quality, leading to an increase in their market share. This competitive dynamic showcases the evolving landscape of the infusion therapy market, where homecare settings provide comfort and accessibility, while hospitals push for technological advancements. ### By Product: Smart Infusion Pumps (Largest) vs. Portable Infusion Devices (Fastest-Growing) The US home infusion-therapy-devices market is characterized by a diverse range of product segments, with smart infusion pumps commanding the largest market share. This segment is favored for its advanced technology and efficiency in delivering medications accurately, making it a preferred choice among healthcare providers. Portable infusion devices and complex infusion systems follow, catering to specific patient needs and environments. In recent years, the market has seen a significant rise in demand for portable infusion devices, which are recognized as the fastest-growing segment. This growth is driven by advancing technology that enhances portability and usability, along with a rising preference for home-based therapies among patients. The increasing prevalence of chronic diseases and a shift towards outpatient care are further fueling these trends. Smart Infusion Pumps (Dominant) vs. Portable Infusion Devices (Emerging) Smart infusion pumps are the dominant segment within the US home infusion-therapy-devices market, known for their precision in drug delivery and ability to integrate with electronic health records. These devices are designed to enhance patient safety and improve the clinical workflow for healthcare providers. Innovations such as smart alarms and dosage calculators contribute to their widespread adoption. On the other hand, portable infusion devices represent an emerging segment, appealing to patients requiring mobility and convenience. These devices are lightweight and compact, enabling therapeutic delivery in a home setting or on the go. The trend towards home infusion therapy is boosting the adoption of portable devices, which offer significant advantages for patient autonomy and comfort. ## Competitive Benchmarking The home infusion-therapy-devices market is characterized by a dynamic competitive landscape, driven by increasing demand for at-home healthcare solutions and advancements in technology. Key players such as Baxter International Inc (US), ICU Medical Inc (US), and Fresenius Kabi AG (DE) are strategically positioned to leverage these trends. Baxter International Inc (US) focuses on innovation in infusion systems, emphasizing the development of smart devices that enhance patient safety and improve outcomes. Meanwhile, ICU Medical Inc (US) has been expanding its product portfolio through strategic acquisitions, aiming to consolidate its market presence and enhance its technological capabilities. Fresenius Kabi AG (DE) appears to be concentrating on regional expansion, particularly in North America, to capitalize on the growing demand for home healthcare services.The business tactics employed by these companies include localizing manufacturing and optimizing supply chains to enhance efficiency and reduce costs. The market structure is moderately fragmented, with several players competing for market share. However, the collective influence of these key players shapes the competitive environment, as they continuously innovate and adapt to changing consumer needs. In October Baxter International Inc (US) announced the launch of a new infusion pump that integrates advanced software for real-time monitoring of medication delivery. This strategic move is significant as it not only enhances patient safety but also positions Baxter as a leader in the digital transformation of infusion therapy. The integration of technology into their devices reflects a broader trend towards smart healthcare solutions. In September ICU Medical Inc (US) completed the acquisition of a smaller competitor specializing in home infusion devices. This acquisition is likely to strengthen ICU Medical's market position and expand its product offerings, allowing for a more comprehensive solution for home healthcare providers. The strategic importance of this move lies in the potential for increased market share and enhanced innovation capabilities. In August Fresenius Kabi AG (DE) announced a partnership with a telehealth company to develop integrated solutions for remote patient monitoring. This collaboration is indicative of the growing trend towards digital health solutions, which are becoming increasingly vital in the home infusion market. By combining their infusion devices with telehealth capabilities, Fresenius Kabi aims to improve patient outcomes and streamline healthcare delivery. As of November current competitive trends in the home infusion-therapy-devices market include a strong emphasis on digitalization, sustainability, and the integration of artificial intelligence (AI) into healthcare solutions. Strategic alliances are increasingly shaping the landscape, as companies recognize the value of collaboration in driving innovation. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on technological advancements, supply chain reliability, and the ability to deliver comprehensive, patient-centered solutions. ## Recent News & Developments The US Home Infusion Therapy Devices Market has recently been influenced by significant developments, including advancements in technology and an increasing shift towards home healthcare. Companies such as Baxter International and Medtronic are focusing on innovative infusion devices designed to enhance patient safety and comfort. In October 2023, C.R. Bard announced a strategic partnership aimed at expanding their product range in the home infusion sector. Growth in market valuation for firms like Fresenius Kabi and B. Braun Melsungen is also notable, with recent projections indicating a surge in demand for at-home healthcare solutions driven by the aging population and preference for at-home treatments. The COVID-19 pandemic catalyzed changes in healthcare delivery, intensifying interest in home infusion therapies. In terms of mergers and acquisitions, Smiths Medical completed the acquisition of CareFusion in September 2022 to strengthen its portfolio in the home infusion segment. Furthermore, in July 2022, ICU Medical acquired the assets of Halyard Health, further consolidating its position in the market. Overall, the landscape of the US Home Infusion Therapy Devices Market continues to evolve, supported by a focus on innovation and partnerships. ## Report Scope | MARKET SIZE 2024 | 1434.3(USD Million) | | --- | --- | | MARKET SIZE 2025 | 1507.31(USD Million) | | MARKET SIZE 2035 | 2477.0(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 5.09% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Baxter International Inc (US), B. Braun Melsungen AG (DE), Fresenius Kabi AG (DE), Medtronic plc (IE), Smiths Medical (US), Terumo Corporation (JP), ICU Medical Inc (US), Halyard Health Inc (US) | | Segments Covered | Device Type, Application, End User, Product | | Key Market Opportunities | Integration of advanced digital health technologies enhances patient monitoring in the home infusion-therapy-devices market. | | Key Market Dynamics | Rising demand for home infusion-therapy-devices driven by technological advancements and shifting patient care preferences. | | Countries Covered | US | ## Frequently Asked Questions **Q: What is the current valuation of the US home infusion-therapy-devices market?** A: The market valuation was $1434.3 Million in 2024. **Q: What is the projected market size for the US home infusion-therapy-devices market by 2035?** A: The projected valuation for 2035 is $2477.0 Million. **Q: What is the expected CAGR for the US home infusion-therapy-devices market during the forecast period 2025 - 2035?** A: The expected CAGR is 5.09% during the forecast period. **Q: Which device type segment had the highest valuation in 2024?** A: Infusion Pumps had the highest valuation, ranging from $400.0 Million to $700.0 Million. **Q: What is the valuation range for the Pain Management application segment?** A: The valuation range for Pain Management is $350.0 Million to $600.0 Million. **Q: Which end user segment is projected to dominate the market in 2035?** A: Homecare Settings is projected to dominate, with a valuation range of $800.0 Million to $1300.0 Million. **Q: What is the valuation range for Smart Infusion Pumps in 2024?** A: Smart Infusion Pumps had a valuation range of $500.0 Million to $850.0 Million. **Q: Who are the key players in the US home infusion-therapy-devices market?** A: Key players include Baxter International Inc, B. Braun Melsungen AG, and Fresenius Kabi AG. **Q: What is the valuation range for IV Sets in 2024?** A: The valuation range for IV Sets is $300.0 Million to $500.0 Million. **Q: Which application segment is expected to grow the most by 2035?** A: Hydration Therapy is expected to grow significantly, with a valuation range of $334.3 Million to $627.0 Million. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-home-infusion-therapy-devices-market-19669*